ZymoGenetics Allies With Bayer To Blitz U.S. Hospital Market With rhThrombin

Bayer receives ex-U.S. rights to develop and market the recombinant thrombin therapy.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet